Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 represent the core transcriptional circuitry responsible for maintaining the undifferentiated state and self-renewal capacity of pluripotent stem cells (Boyer et al., 2005; Cell). These elements, primarily enhancers and promoters, serve as docking sites for the transcription factors OCT4 (POU5F1), SOX2, and KLF4, which cooperatively regulate the expression of genes essential for stemness, such as NANOG (Chambers & Tomlinson, 2009; Development). In a therapeutic context, these genomic regions are critical for cellular reprogramming into induced pluripotent stem cells (iPSCs) (Takahashi & Yamanaka, 2006; Cell). However, their dysregulation is frequently observed in various cancers, where they drive the cancer stem cell phenotype, leading to tumor progression, chemoresistance, and metastasis (Young, 2011; Cell). While these DNA elements themselves are not traditional targets for small molecule drugs, they are central to gene therapy and genome editing strategies aimed at modulating cell fate or treating malignancies. The precise control of these elements is vital, as improper activation can lead to the formation of teratomas or other off-target developmental effects.
Modulation of gene expression through the recruitment of transcriptional co-activators, such as p300 and Mediator, and chromatin remodeling complexes to specific genomic loci to maintain stemness or induce reprogramming.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 (OSK-bound regulatory elements).